News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvilex Associate Expands Ownership of Patents to Include Production of Therapeutic Antibodies


12/20/2011 7:53:43 AM

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) through their associate, Singapore based biotechnology group SG Austria, announced the expanded ownership of patents controlling production of therapeutic antibodies. This will lead to future expanded revenue potential. This particular patent family covers encapsulation of therapeutic antibodies made to aid the immune system fight disease.

Read at BioSpace.com

comments powered by Disqus
Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES